NCT07698366

Brief Summary

This multicenter study aims to evaluate whether active breast ultrasound screening can improve the early diagnosis rate of breast cancer in women aged 65 to 80 years, compared with routine elderly health management. The study uses a mixed cluster-individual randomized design based on community implementation capacity. A subgroup of pilot communities will simultaneously collect ultrasound AI data for research performance analysis only, without affecting clinical diagnosis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82,440

participants targeted

Target at P75+ for not_applicable

Timeline
41mo left

Started Jul 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jul 2026Dec 2029

First Submitted

Initial submission to the registry

July 8, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2029

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

3 years

First QC Date

July 8, 2026

Last Update Submit

July 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Absolute difference in early-stage breast cancer diagnosis rate

    Proportion of pathologically confirmed breast cancer cases at stage I or stage II, compared between the ultrasound screening group and the routine management group within 2-year follow-up.

    24 months after enrollment

Secondary Outcomes (1)

  • Overall breast cancer detection rate

    24 months

Study Arms (2)

Ultrasound Active Screening Group

EXPERIMENTAL

Participants receive one standardized breast ultrasound examination performed by certified primary care physicians during annual health check-ups. In selected pilot communities, an ultrasound AI system is deployed synchronously for image data collection and retrospective scientific analysis only; AI results do not affect clinical diagnosis or report issuance.

Procedure: Standardized Breast Ultrasound Screening

Routine Health Management Group

NO INTERVENTION

Participants receive conventional community health management and annual physical examination according to local routine practice, without study-specific breast ultrasound screening.

Interventions

Retrospective AI image analysis for research use only, not involved in clinical decision-making.

Ultrasound Active Screening Group

Eligibility Criteria

Age65 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Female participants aged 65-80 years.
  • Local residents living in participating communities for ≥6 months.
  • Signed informed consent and willingness to participate.

You may not qualify if:

  • History of breast cancer or previous breast cancer treatment.
  • Breast cancer screening within the past 2 years.
  • Severe comorbid conditions that may affect study participation or follow-up.
  • Acute breast disease or conditions requiring immediate treatment.
  • Unable to cooperate with screening procedures due to physical or cognitive limitations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kunshan First People's Hospital

Kunshan, Jiangsu, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Ge Ma, doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 13, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

July 10, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

July 14, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because there is currently no approved data sharing policy for this multicenter study. De-identified participant data will be managed in accordance with institutional regulations and applicable ethical and legal requirements.

Locations